Геморрагическая лихорадка с почечным синдромом: проблема нефролога


*

Обсуждаются особенности эпидемиологии, патогенеза, клинической картины и лечения различных вариантов геморрагической лихорадки с почечным синдромом.

Литература


1. Сиротин Б.З. Пути развития и особенности патологии почек пригеморрагической лихорадке. Тер. арх. 1981; 6: 64–67.


2. Николаев А.Ю. Геморрагическая лихорадка с почечным синдромом.В: Тареева И.Е. (ред.) Нефрология. Руководство для врачей.М., Медицина, 2000, 572–577.


3. Muranyi W., Bahr U., Zeier M. et al. Hantavirus infection. J. Am. Soc.Nephrol. 2005; 16: 3669–3779.


4. Schreiber M., Laue T., Wolff C. Hantavirus pulmonary syndrome in Germany.Lancet 1996; 347: 1417


5. Hjelle B., Jenison S., Goade D. et al. Hantaviruses: clinical, microbiologic andepidemiologic aspects. Crit. Rev. Clin. Lab. Sci. 1995; 32: 469–508.


6. Faulde M., Sobe D., Kimmig P., Scharninghausen J. Renal failure andhantavirus infection in Europe. Nephrol. Dial. Transplant. 2000;15: 751–753.


7. Cebalo L., Dusek T., Kuzman I., Markotic A. Grading the severity of diseasein patients with Puumala or Dobrava virus infections from 1995 to 2000 inCroatia. Acta Med. Croatica 2003; 57: 355–359.


8. Mustonen J., Partanen J., Kanerva M.. et al. Genetic susceptibility to severecourse of nephropathia epidemica caused by Puumala hantavirus. Kidney Int1996; 49: 217–221.


9. Kilpatrick E.D., Terajima M., Koster F.T. et al. Role of specific CD8-T cellsin the severity of a fulminant zoonotic viral hemorrhagic fever, hantaviruspulmonary syndrome. J. Immunol. 2004; 172: 3297–3304.


10. Mackow E.R., Gavrilovskaya I.N. Cellular receptors and hantaviruspathogenesis. Curr Top Microbiol Immunol 256: 2001; 91–115.


11. Kanerva M., Mustonen J., Vaheri A. Pathogenesis of Puumala and otherhantavirus infections. Rev. Med. Virol. 1998; 8: 67–86.


12. Markotic A., Hensley L., Geisbert T. et al. Hantaviruses induce cytopathiceffects and apoptosis in continuous human embryonic kidney cells. J. Gen. Virol.2003; 84: 2197–2202.


13. Khaiboullina S.F., St Jeor S.C. Hantavirus immunology. Viral Immunol.2002; 15: 609–625.


14. Groen J., Gerding M., Jordans J.G. et al. Class and subclass distributionof Hantavirus-specific serum antibodies at different times after the onset ofnephropathia epidemica. J. Med. Virol. 1994; 43: 39–43.


15. Zaki S.R., Greer P.W., Coffield L.M. et al. Hantavirus pulmonarysyndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol.1995; 146: 552–579.


16. Linderholm M., Ahlm C., Settergren B. Elevated plasma levels of tumornecrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, andIL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis.1996; 173: 38–43.


17. Makela S., Mustonen J., Ala-Houhala I. et al. Urinary excretion of interleukin-6correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am.J. Kidney Dis. 2004; 43: 809–816.


18. Klingstrom J., Plyusnin A., Vaheri A., Lundkvist A. Wildtype Puumalahantavirus infection induces cytokines, C-reactive protein, creatinine, andnitric oxide in cynomolgus macaques. J. Virol. 2002; 76: 444–449.


19. Lima E.Q., Nogueira M.L. Viral hemorrhagic fever-induced acute kidneyinjury. Semin. Nephrol. 2008; 28(4): 409–415.


20. Sion M.L., Hatzitolios A.I., Armenaka M.C. et al. Acute renal failure causedby leptospirosis and Hantavirus infection in an urban hospital. Eur. J. Intern.Med. 2002; 13(4): 264–268.


21. Courouble P., Vanpee D., Delgrange E. et al. Hantavirus infections: clinicalpresentation in the emergency room. Eur. J. Emerg. Med. 2001; 8(1): 17–20.


22. Li Z., Bai X., Bian H. Serologic diagnosis of Hantaan virus infection based ona peptide antigen. Clin. Chem. 2002; 48: 645–647.


23. Zeier M., Ritz E. Hantavirus-induced acute renal failure. Internist 1996;37: 1092–1095.


24. Шутов А.М., Савинова Г.А., Киселев Л.И. и др. Применениерекомбинантного интерлейкина-2 при геморрагической лихорадке спочечным синдромом. Клин. мед. 2002; 80(4): 54–57.


25. Makela S., Ala-Houhala I., Mustonen J. et al. Renal function and bloodpressure five years after puumala virus-induced nephropathy. Kidney Int. 2000;58(4): 1711–1718.


26. Дударев М.В., Пименов Л.Т. Отдаленные исходы и формированиехронической почечной недостаточности у перенесших геморрагическуюлихорадку с почечным синдромом. Тер. арх. 2008; 6: 59–62.


Похожие статьи


Бионика Медиа